AllergiClear-M
NDC 68703-341, Adrenalinum, Calcarea fluorica, Calcarea phosphorica, Euphrasia officinalis, Histaminum hydrochloricum, Kali muriaticum, Natrum muriaticum, Silicea, liquid, from Silver Star Brands.
- Product NDC
- 68703-341
- Status
- Listed
- Labeler
- Silver Star Brands
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68703-341 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CALCIUM PHOSPHATE8 [hp_X]/59mL
- CALCIUM FLUORIDE8 [hp_X]/59mL
- EUPHRASIA OFFICINALIS LEAF4 [hp_X]/59mL
- EPINEPHRINE7 [hp_C]/59mL
- HISTAMINE DIHYDROCHLORIDE7 [hp_C]/59mL
- SILICON DIOXIDE8 [hp_X]/59mL
- SODIUM CHLORIDE8 [hp_X]/59mL
- POTASSIUM CHLORIDE8 [hp_X]/59mL
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Blood Coagulation Factor [EPC]; Calcium [CS]; Catecholamine [EPC]; Catecholamines [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Salt [EPC]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68703-341-02 | 68703034102 | 59 mL in 1 BOTTLE, DROPPER (68703-341-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 68703-341 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68703-341 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68703-341. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.